![(3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-4-{[(2R,4R,5R,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12-dihydroxy-3,5,7,9,11,13-hexamethyloxacyclotetra](https://static.cymitquimica.com/cas-image/328126-3r-4s-5s-6r-7r-9r-11r-12s-13r-14r-4-2r-4r-5r-6s-45-dihydroxy-46-dimethyltetrahydro-2h-pyran-2-yl-oxy-6-2s-3r-4s-6r-4-dimethylamino-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl-oxy-14-ethyl-712-dihydroxy-35791113-hexamethyloxacyclotetra.png)
CAS: 33442-56-7 - (3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-4-{[(2R,4R,5R,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12-dihydroxy-3,5,7,9,11,13-hexamethyloxacyclotetra
Fórmula:C36H65NO12
InChI:InChI=1/C36H65NO12/c1-13-25-19(4)28(39)20(5)27(38)17(2)15-36(10,44)32(49-34-29(40)24(37(11)12)14-18(3)45-34)21(6)30(22(7)33(42)47-25)48-26-16-35(9,43)31(41)23(8)46-26/h17-26,28-32,34,39-41,43-44H,13-16H2,1-12H3/t17-,18-,19+,20+,21+,22-,23+,24+,25-,26+,28+,29-,30+,31-,32-,34+,35-,36-/m1/s1
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | Erythromycin EP Impurity K (Erythromycin D) REF: 4Z-E-2043CAS: 33442-56-7 | - - - | A consultar | Seg 22 Jul 24 |
 | Erythromycin impurity K REF: 3D-IE167812CAS: 33442-56-7 | Min. 95% | A consultar | Sex 26 Jul 24 |
Ref: 4Z-E-2043
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada em Estados Unidos, Segunda-feira 22 de Julho de 2024
Erythromycin impurity K
CAS:33442-56-7
Erythromycin impurity K is a synthetic impurity of erythromycin, which is an antibiotic drug product. …
Fórmula:
C36H65NO12
Pureza:
Min. 95%
Peso molecular:
703.9 g/mol
Ref: 3D-IE167812
| Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Sexta-feira 26 de Julho de 2024
